-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

641.O1.6 641. Chronic Lymphocytic Leukemia: Basic and Translational: Therapeutic Vulnerabilities, Signaling, and Microenvironment

Symposia: Chronic Lymphocytic Leukemia: Basic and Translational Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Lymphoid Leukemias, Fundamental Science, Apoptosis, Artificial intelligence (AI), Translational Research, CLL, Bioinformatics, Diseases, Immune mechanism, Immunology, Lymphoid Malignancies, Metabolism, Computational biology, Biological Processes, Molecular biology, Technology and Procedures, Study Population, Human, Multi-systemic interactions, Profiling, Pathogenesis, Machine learning, Molecular testing, Omics technologies
Saturday, December 7, 2024: 9:30 AM-11:00 AM
Marriott Grand Ballroom 5-6 (Marriott Marquis San Diego Marina)
Moderators:
Lili Wang, MD, PhD, City of Hope and Elisa Ten Hacken, PhD,
Disclosures:
No relevant conflicts of interest to declare.

Presentations in this session will cover emerging novel preclinical strategies for therapeutically targeting CLL, including targeting of disease reservoirs (residual disease, proliferative fraction). In addition, data on CLL-related T cell and immune function will be presented with potential therapeutic and/or prognostic significance.
9:30 AM

Lodovico Terzi Di Bergamo1*, Gabriela Forestieri1*, Jui Wan Loh2*, Amartya Singh3*, Valeria Spina4*, Federico Jauk, MD1*, Antonella Zucchetto, PhD5*, Adalgisa Condoluci, MD1, Alessio Bruscaggin, PhD1*, Katia Pini1*, Deborah Piffaretti, PhD6*, Elisa Civanelli, MSc7*, Chiara Tarantelli, PhD7*, Matin Salehi1*, Ilaria Romano, MD1, Maria Cristina Pirosa, MD1, Simone Bocchetta, PhD1*, Georgia Alice Galimberti8*, Tamara Bittolo, PhD5*, Erika Tissino, PhD9*, Lorenzo De Paoli10*, Clara Deambrogi11*, Anna Maria Frustaci, MD12*, Francesco Autore, MD, PhD13*, Michele Merli14*, Lydia Scarfo, MD15, Silvia Rasi16*, Marina Deodato, MD12*, Jakob Passweg Sr.17, Riccardo Moia, MD18*, Claudio Martines, PhD19*, Paolo Ghia20, Franco Cavalli, MD21*, Emanuele Zucca, MD22, Bernhard Gerber23*, Georg Stüssi, MD23*, Marco Montillo24, Francesco Passamonti, MD25*, Michael Gregor, MD26*, Luca Laurenti, MD27*, Alessandra Tedeschi, MD12*, Alexandar Tzankov, MD, PhD28*, Francesco Bertoni, MD29, Gianluca Gaidano, MD, PhD18, Dimitar G Efremov, MD, PhD30, Valter Gattei, MD5,31, Hossein Khiabanian, PhD3* and Davide Rossi, MD, PhD1

1Institute of Oncology Research, Laboratory of Experimental Hematology, Bellinzona, Switzerland
2Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore
3Rutgers University, New Brunswick, NJ
4Laboratorio di Diagnostica Molecolare, Servizio di Genetica Medica EOLAB, Ente Ospedaliero Cantonale, Bellinzona, Switzerland
5Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy
6Institute of Oncology Research, Laboratory of Experimental Hematology, Bellinzona, AL, Switzerland
7Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland
8Institute of Oncology Research, Bellinzona, Switzerland
9Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Pn, Italy
10Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
11Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, ITA
12Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
13Hematology Section, Department of Radiological and Hematological Science, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
14Hematology, University Hospital "Ospedale di Circolo e Fondazione Macchi" - ASST Sette Laghi, Varese, Italy
15Division of Experimental Oncology, IRCCS Ospedale San Raffaele Milan Italy., Milano, Italy
16Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Novara, ITA
17University Hospital Basel, Basel, Switzerland
18Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy
19Molecular Hematology, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy
20Medical School, Università Vita-Salute San Raffaele, Milano, Italy
21Fondazione per l’Istituto Oncologico di Ricerca, Bellinzona, Switzerland
22IOSI-Oncology Inst. of Southern Switzerland, Bellinzona, Ticino, Switzerland
23Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale, Bellinzona, Switzerland
24Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Italy, Milano, Italy
25Ospedale Di Circolo E Fondazione Macchi, Varese, ITA
26Division of Hematology, Cantonal Hospital of Lucerne, Lucerne, Switzerland, Lucerne, Switzerland
27Hematology Section, Department of Radiological and Hematological Sciences, Catholic University of Sacred Heart, Rome, Italy
28Medical Genetics and Pathology, University of Basel, Basel, Switzerland
29Institute of Oncology Research, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
30Molecular Hematology, International Centre for Genetic Engineering and Biotechnology, Trieste, TS, Italy
31Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano, Italy

9:45 AM

Shih-Shih Chen, PhD1, Susan Buhl2*, Anita Kar Yun Ng3, Laila Schipper1*, Bianca Cinquemani4*, Nikhil Trepeta5*, Martina Cardillo, PhD3*, Gonzalo Blanco3*, Kelly Wong1*, Yu-Ju Chen1*, Xiao J. Yan3, Matthew Scharff6* and Nicholas Chiorazzi3

1Institute of Molecular Medicine, The Feinstein Institutes for Medical Research, Northwell Health System, Manhasset, NY, Manhasset, NY
2Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY
3Karches Center for Oncology Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY
4Institute of Molecular Medicine, The Feinstein Institutes for Medical Research, Northwell Health System, Manhasset, NY, Manhasset
5Institute of molecular medicine, The Feinstein Institutes for Medical Research, Northwell Health System, Manhasset, NY, Manhasset, NY
6Albert Einstein College of Medicine, Bronx, NY

10:00 AM

Filippo Vit, MSc1*, Tamara Bittolo, PhD1*, Antonella Zucchetto, PhD1*, Robel Papotti, PhD1*, Erika Tissino, PhD2*, Federico Pozzo, PhD1*, Andrea Stacchetti, PhD1*, Francesca Rossi, PhD1*, Massimo Degan, PhD1*, Eva Zaina1*, Ilaria Cattarossi1*, Paola Varaschin1*, Paola Nanni1*, Michele Berton1*, Alessandra Braida1*, Roberta Laureana, MD3*, Annalisa Chiarenza4*, Jacopo Olivieri, MD5*, Azzurra Anna Romeo, MD6*, Annalisa Biagi, MD6*, Giovanni D'Arena, MD7*, Enrica Antonia Martino8*, Pietro Bulian9*, Massimo Gentile, MD8,10*, Massimiliano Postorino, MD11*, Laura Ballotta, MD12*, Francesco Zaja, MD12*, Francesco Di Raimondo, MD, Prof13, Maria Ilaria Del Principe3*, Valter Gattei, MD1 and Riccardo Bomben, PhD1*

1Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy
2Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Pn, Italy
3Hematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
4Hematology and Bone Marrow Transplatation Unit, U.O.C. Ematologia, A.O.U. Poiliclinico G.Rodolico-S.Marco, Catania, Italy
5Clinica Ematologica, Centro Trapianti e Terapie Cellulari "Carlo Melzi", Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
6Hematology and Transplant Unit, Ospedale S.M.Goretti, AUSL Latina, Italy, Latina, Italy
7Haematology Unit, ASL di Salerno - PO San Luca, Salerno, Italy
8Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy, Cosenza, Italy
9Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, Aviano, Italy
10Department of Pharmacy, Health and Nutritional Science, University of Calabria, Rende, Italy
11Department of Onco-hematology, Fondazione Policlinico Tor Vergata, Rome, Italy
12Department of Medical, Surgical and Health Sciences, University of Trieste, Italy, Trieste, Italy
13Division of Hematology, Policlinico, Department of Surgery and Medical Specialties, University of Catania, Catania, Catania, Italy, Catania, Italy

10:15 AM

Elisa Ten Hacken, PhD1,2, Johan Gustafsson, PhD3,4,5*, Chiara Tomasoni, PhD1*, Gabriela Brunsting Hoffmann6*, Kayla Cruz6*, Wesley S Lu, BS7*, Shuqiang Li8*, Nicholas Haradhvala, PhD3*, Connor Johnson, BA3*, Stephanie Deng2*, Xia Bu, PhD2*, Donna S. Neuberg, ScD9, Othman Al-Sawaf, MD10, Barbara F. Eichhorst, MD10, Clare Sun, MD11, Erin M. Parry, MD, PhD2,3,12,13, Gordon J. Freeman, PhD2,13*, Gad Getz, PhD3,14,15* and Catherine J. Wu, MD2,3,12,13*

1Division of Hematology and Medical Oncology, Weill Cornell Medical College, Weill Cornell Medicine, New York City, NY
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
3Broad Institute of MIT and Harvard, Cambridge, MA
4TIMM Laboratory at Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sweden
5Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
6Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA
7Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA
8Dana Farber Cancer Institute, Translational Immunogenomics Laboratory, Boston, MA
9Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
10Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne, Cologne, Germany, Cologne, Germany
11National Heart, Lung, and Blood Institute, National Heart, Lung and Blood Institute, Bethesda, MD
12Brigham and Women's Hospital, Boston, MA
13Harvard Medical School, Boston, MA
14Department of Pathology, Massachusetts General Hospital, Boston, MA
15Krantz Family Center for Cancer Research and Dept. of Pathology, Massachusetts General Hospital, Boston, MA

10:30 AM

Tiana Huynh1*, Sonia Rodriguez-Rodriguez, PhD2*, Carly Roleder1*, Sarah Whelan3*, May Tan3*, Ernestine Lee3*, Paul Munson3* and Alexey V. Danilov, MD, PhD4

1City of Hope, Duarte, CA
2Stem Cell Biology & Regenerative Medicine, Beckman Research Institute of City of Hope, Duarte, CA
3Nurix Therapeutics, Inc., San Francisco, CA
4City of Hope National Medical Center, Duarte, CA

10:45 AM

Matthew J. Cortese, MD, MPH, MD, MPH1, Jacob P Wright2*, Cory Mavis, MSc3*, Taylor K Mandeville, BA3*, Alex Niu, MD4*, Dae-Kyum Kim, PhD5*, Spencer Rosario, PhD6* and Francisco Hernandez-Ilizaliturri, MD4

1Department of Medicine - Lymphoma Section, Department of Cancer Genetics & Genomics, Roswell Park Comprehensive Cancer Center, Amherst, NY
2Department of Biological Sciences, State University of New York (University at Buffalo), Buffalo, NY
3Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
4Department of Medicine (Lymphoma Section), Roswell Park Comprehensive Cancer Center, Buffalo, NY
5Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY
6Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY

*signifies non-member of ASH